EUnetHTA Joint Action 2010–2012 | EUnetHTA Joint action 2010-2012 Sharing expertise and efforts...

12
EUnetHTA Joint Action 2010–2012 | www.eunethta.eu EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA European Patients’ Forum Spring Seminar on HTA 18 May 2010 Brussels

Transcript of EUnetHTA Joint Action 2010–2012 | EUnetHTA Joint action 2010-2012 Sharing expertise and efforts...

Page 1: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA Joint Action 2010–2012 | www.eunethta.eu

EUnetHTA Joint action 2010-2012

Sharing expertise and efforts

Iris Pasternack, research officer, FINOHTA

European Patients’ Forum Spring Seminar on HTA

18 May 2010 Brussels

Page 2: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu2 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

What is EUnetHTA?

• European network for HTA• 2006-2008 EUnetHTA project• 2009 EUnetHTA Collaboration • 2010-2012 Joint Action between European

Commission and EU Member States– A total of 33 government appointed organisations

from 23 EU Member States and Norway and a large number of relevant regional agencies and non-for-profit organisations that produce or contribute to HTA

Page 3: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu3 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

Partner

EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

EUnetHTAJoint Action

Associated Partners

EUnetHTA Collaboration

Founding Partners

EUnetHTA Project Associated Partners

Partner

Partner

Partner

Partner

Partner

Partner

Partner

Partner

Partner

Partner

PartnerPartner

PartnerPartner

Partner Partner

Partner

Partner

Partner

Partner

Partner

A Venn Diagram to illustrate the transition from EUnetHTA Project Associate Partnership to EUnetHTA Collaboration Founding Partnership to Joint Action Associate Partnership

Page 4: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu4 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

Why EUnetHTA?

• Double work could be avoided– Example: cancer drugs

• Relevance of HTA can be improved– Example: patient perspective in surgery for

severe obesity

• Quality of HTA can be improved– Example: pool of experts

Page 5: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu5 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

Stakeholder Forum

Plenary Assembly(policy setting)

Secretariat

reporting control

reporting control

reporting support/control

coordination /exchange of info

Determineactivities

Work

Package

EU

Institutions

info

Executive Committee (strategic planning of activities)

Work

Package Work

Package Work

Package Work

Package Work

Package Work

Package Work

Package

info

Page 6: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu6 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

What is HTA Core Model?

• An online-tool for HTA-developers

• Contains – structure for HTA generation and reporting

– advice on methodologies

• What is new? Information is split into elements

Page 7: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu7 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

1. Health problem and current use of technology

2. Description and technical characteristics

3. Safety

4. Clinical effectiveness

5. Costs and economic evaluation

6. Ethical analysis

7. Organisational aspects

8. Social aspects

9. Legal aspects

Domains of the HTA Core Model

Page 8: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu8 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

Social aspects

Topic 1: Major life areas

Topic 2: Individual

Topic 3: Communication

Which social areas does the use of the technology influence?

Who are the important others that the use of the technology may affect in addition to the patient?

What kind of support and resources are needed or might be released as the technology is put to use?

What kinds of changes does the use of the technology generate in the patient's role in the major life areas?

What kind of changes does the implementation and use of the technology mean for the patients physical and psychological functioning in his or her major life areas?

How do patients and important others react and act upon the technology?

What is patients' and important others’ knowledge and understanding of the technology?

How is the information regarding the use of the technology processed and exchanged?

What are the consequences in decision making?

Page 9: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu9 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

Social aspectsTopic 1: Major life areas

Issue 1: Which social areas does the use of the technology influence?

Issue 2: Who are the important others that the use of the technology may affect in addition to the patient?

Issue 3: What kind of support and resources are needed or might be released as the technology is put to use?

Issue 4: What kinds of changes does the use of the technology generate in the patient's role in the major life areas?

Issue 5: What kind of changes does the implementation and use of the technology mean for the patients physical and psychological functioning in his or her major life areas?

Page 10: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu10 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

Social aspectsTopic 2: Individual

Issue 6: How do patients and important others react and act upon the technology?

Topic 3: Communication

Issue 7: What is patients' and important others’ knowledge and understanding of the technology?

Issue 8: How is the information regarding the use of the technology processed and exchanged?

Issue 9: What are the consequences in decision making?

Page 11: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu11 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

How to get involved with EUnetHTA?

• EUnetHTA Stakeholder Forum• Public consultations on deliverables

and certain documents• Targeted inquiries on specific subjects

emerging from the work performed in the EUnetHTA JA Work Packages

• Stakeholder Involvement online area within the EUnetHTA website will be developed during 2010

Page 12: EUnetHTA Joint Action 2010–2012 |  EUnetHTA Joint action 2010-2012 Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.

EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu12 Joint Action 2010–2012EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Joint Action 2010–2012

EUnetHTA Collaboration: how to ensure continuity?

• Focus on methodology but ALSO on a working process (i.e. developing practical tools)

• Strong emphasis on the management and organisational support structures for co-operation

• Stakeholder involvement, openness to dialogue and inclusiveness

• Attention to the policy processes in European healthcare• Continuous attention to delivering a unique and added

value to partners and users